Recently, hematopoietic stem cells (identified as CD133+CD34+CD45+ cells) were also found in the peripheral blood of patients with lung cancer, and their number negatively correlated with time to progression (Vroling et al. 2010). This evidence concerns the gene PROM1 and lung carcinoma.